MRNA VACCINES POSE ONGOING CONCERNS IN CHILDREN -AIRDATE: December 19, 2024

A new pediatric study on the effectiveness of the COVID vaccinations on children aged 6 months to 4 years in age has a shocking conclusion. Meanwhile, Moderna is developing an mRNA vaccine for RSV for children that has undergone several safety pauses because of severe injury to babies.

AIRDATE: December 19, 2024

https://thehighwire.com/ark-videos/mrna-vaccines-pose-ongoing-concerns-in-children/